CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionPrice-to-book is 9.47×, higher than 95% of its Medical Instruments & Supplies peers (median 2.65×)
- FinancialsAltman Z-Score 1.74: grey zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.09BCNY606.82M · vs all stocks (USD)
Revenue (TTM)
421.50MCNY62.60M · vs all stocks (USD)
Profit Margin
-17.97%vs Medical Instruments & Supplies peers
Beta
0.7500xvs all stocks
52-Week Change
-53.21%vs all stocks
Market Capitalization
4.09BCNY606.82M · vs all stocks (USD)
Enterprise Value
4.82BCNY715.32M · vs all stocks (USD)
Forward P/E
10.26xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
10.43xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
9.47xvs Medical Instruments & Supplies peers
Enterprise to Revenue
11.43xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-87.56xvs Medical Instruments & Supplies peers
Gross Margin
29.56%vs Medical Instruments & Supplies peers
Profit Margin
-17.97%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-2.85%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-14.15%vs Medical Instruments & Supplies peers
Revenue (TTM)
421.50MCNY62.60M · vs all stocks (USD)
Revenue per Share (TTM)
0.6590CNYUpdated Aug 19, 2026Quarterly Revenue Growth
6.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
99.24MCNY14.74M · vs all stocks (USD)
EBITDA (TTM)
-55.00MCNY-8.17M · vs all stocks (USD)
Net Income (TTM)
-75.73MCNY-11.25M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
264.50%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
98.49MCNY14.63M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
106.73MCNY15.85M · vs all stocks (USD)
5-Year Average Dividend Yield
0.22%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
17.65MCNYFY2025 · Dec 31, 2025Revenue
413.76MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
305.43MCNYFY2025 · Dec 31, 2025Gross Profit
108.33MCNYFY2025 · Dec 31, 2025Operating Income
-43.18MCNY-6.41M · vs all stocks (USD)
Pre-tax Income
-79.76MCNYFY2025 · Dec 31, 2025Income Tax Expense
2.11MCNYFY2025 · Dec 31, 2025Net Income
-81.87MCNYFY2025 · Dec 31, 2025EBIT
-61.55MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-27.69MCNYFY2025 · Dec 31, 2025Research & Development
22.51MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
22.96MCNYFY2025 · Dec 31, 2025Other Operating Expenses
2.88MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
470.20KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
18.21MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1300CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
640.11MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
640.11MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-81.87MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.34MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
90.00MCNYFY2025 · Dec 31, 2025Free Cash Flow
80.22MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
357.72MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-81.87MCNYFY2025 · Dec 31, 2025Other Non-cash Items
20.31MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
148.75MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
2.81MCNYFY2025 · Dec 31, 2025Capital Expenditures
-9.78MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-9.78MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.19BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.26BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-16.86MCNYFY2025 · Dec 31, 2025Other Financing Charges
-6.63MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-87.37MCNYFY2025 · Dec 31, 2025Shares Outstanding
658.99MSharesUpdated Aug 19, 2026Float Shares
482.30MSharesUpdated Aug 19, 2026% Held by Insiders
34.08%vs all stocks
% Held by Institutions
2.07%vs all stocks
Total Cash (MRQ)
177.13MCNY26.31M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.2690CNYUpdated Aug 19, 2026Total Debt (MRQ)
580.18MCNY86.17M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.20xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.52xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
0.7040CNYUpdated Aug 19, 2026Total Assets
1.11BCNY165.27M · vs all stocks (USD)
Total Current Assets
977.87MCNYFY2025 · Dec 31, 2025Total Liabilities
641.73MCNYFY2025 · Dec 31, 2025Total Non-current Assets
134.88MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
5.86MCNYFY2025 · Dec 31, 2025Total Current Liabilities
635.87MCNYFY2025 · Dec 31, 2025Cash
335.71MCNYFY2025 · Dec 31, 2025Cash Equivalents
40.96MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
376.67MCNYFY2025 · Dec 31, 2025Accounts Receivable
334.38MCNYFY2025 · Dec 31, 2025Inventory
1.62MCNYFY2025 · Dec 31, 2025Accounts Payable
18.29MCNYFY2025 · Dec 31, 2025Short-term Debt
520.91MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.19MCNYFY2025 · Dec 31, 2025Long-term Debt
427.23KCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
5.34MCNYFY2025 · Dec 31, 2025Common Stock (Book)
658.99MCNYFY2025 · Dec 31, 2025Retained Earnings
-2.09BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
471.02MCNY69.96M · vs all stocks (USD)
52-Week Low
5.56CNYUpdated Aug 19, 202652-Week High
14.20CNYUpdated Aug 19, 202652-Week Change
-53.21%vs all stocks
Beta
0.7500xvs all stocks
50-Day MA
6.83CNYUpdated Aug 19, 2026200-Day MA
9.33CNYUpdated Aug 19, 2026Avg 10-Day Volume
17.97MSharesUpdated Aug 19, 2026Avg 30-Day Volume
21.61MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.1200CNYUpdated Aug 19, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 9.47×, higher than 95% of its Medical Instruments & Supplies peers (median 2.65×)Significant
Price-to-book: 9.47Industry median: 2.65Industry P95: 9.29Peers compared: 65.00
Financial Health
Altman Z-Score 1.74: grey zoneSignificant
Altman Z-Score: 1.74
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Nissei ASB Machine Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Monalisa Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Feida Environmental Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
RS Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Tokyo Keiki Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Newcapec Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Changshu Automotive Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Vatti Corporation Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Kuangshun Photosensitivity Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Haiyang Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Intuitive Surgical, Inc.
2 interpretationsFCF Ratios ElevatedCash-Flow Ratios Elevated
SM Energy Company
2 interpretationsFCF Ratios ElevatedCash-Flow Ratios Elevated
Spire Global Inc.
2 interpretationsFCF Ratios ElevatedCash-Flow Ratios Elevated